Carlos E. Santos - 21 Sep 2026 Form 4 Insider Report for Legend Biotech Corp (LEGN)

Reporting relationship: Chief Financial Officer
Issuer ticker: LEGN
Reported as of: 21 Sep 2026
Net transaction value: -$49,630
SEC form: 4
Accepted by SEC: 23 Sep 2026, 16:15:08 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert Staloff, Attorney-in-Fact

Key filing fact

Carlos E. Santos filed Form 4 for Legend Biotech Corp (LEGN) on 23 Sep 2026.

Key facts

This page summarizes Carlos E. Santos's Form 4 filing for Legend Biotech Corp (LEGN).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 23 Sep 2026, 16:15.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$49,630.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002097065 Primary reporting owner

Santos Carlos E

Relationship: Chief Financial Officer
Address: C/O LEGEND BIOTECH CORP, 77 CORPORATE DRIVE, 4TH FLOOR, BRIDGEWATER
Signature: /s/ Robert Staloff, Attorney-in-Fact
Signature date: 23 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LEGN transaction

Ordinary Shares

Award

Transaction value
Shares: +19,676
Change %
Price: $0.000000^*
Shares after: 19,676
Date: 21 Sep 2026
Ownership: Direct
Footnotes: F1

LEGN transaction

Ordinary Shares

Sale

Transaction value: $49,630
Shares: -5,430
Change %: -28%
Price: $9.14
Shares after: 14,246
Date: 21 Sep 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.

Footnote F2

Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units.

Footnote F3

The price reported in Column 4 is a weighted average price. The prices sold ranged from $8.905 to $9.325 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.